1Paediatric Endocrinology Section, Department of Endocrinology, St. Bartholomew's Hospital, London, UK. c.camacho-hubner@mds.qmw.ac.uk
Insulin-like growth factor (IGF) deficiency can arise from genetic defects or secondary causes like growth hormone issues. Reviewing these conditions and recombinant human IGF-I therapy highlights its metabolic importance.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: